Read Full Article
Kura Oncology, Inc. (Nasdaq: KURA) today announced the appointment of Steven H. Stein, M.D., to its board of directors . Dr. Stein currently serves as ...
We are thrilled to have Steven join our board during this pivotal time at Kura.
I am excited by the encouraging data for tipifarnib in HRAS mutant squamous cell head and neck cancers, the potential of the company's early-stage pipeline, and the management team's rapid execution of its programs.